A NanoString nCounter assay identified tandem gene expression profiles for predicting miRNA targets, where functional studies identified genes involved in cell proliferation and tumour response to chemotherapy, such as the miR-20a/-20b target CDKN1A/p21 and the miR-194 target SOCS2 [38]. The gene discussed is CDKN1A; the disease is neoplasm.